GO:0004818 glutamate-tRNA ligase activity

Glutamate-tRNA ligase activity (GO:0004818) is a molecular function that attaches the amino acid glutamate to its corresponding transfer RNA (tRNA(Glu)), forming glutamyl-tRNA(Glu), a key step in protein synthesis. This reaction is catalyzed by glutamyl-tRNA synthetase (GluRS), an enzyme that belongs to the class I aminoacyl-tRNA synthetases and ensures the fidelity of translation by pairing glutamate with its cognate tRNA. The activity is defined by the reaction ATP + L-glutamate + tRNA(Glu) = AMP + diphosphate + L-glutamyl-tRNA(Glu), which proceeds through an aminoacyl-adenylate intermediate. Beyond its canonical role in translation, GluRS participates in indirect pathways of tRNA aminoacylation, such as the formation of glutaminyl-tRNA(Gln) in organelles and bacteria, where a non-discriminating GluRS charges tRNA(Gln) with glutamate, which is subsequently converted to glutamine. This dual specificity highlights the evolutionary and functional complexity of GluRS and its importance in cellular metabolism. Structural and biochemical studies of GluRS from pathogens such as Plasmodium falciparum have revealed unique features that can be targeted for drug development. Researchers study glutamate-tRNA ligase activity to understand fundamental translation mechanisms, tRNA identity, and the evolution of aminoacyl-tRNA synthetases. The enzyme is also relevant to human health because mutations or dysregulation in aminoacyl-tRNA synthetases are linked to a range of diseases, including neurological disorders and cancer. The catalytic activity of GluRS is sensitive to redox conditions, suggesting that it may integrate cellular redox signals with translation. This article provides a comprehensive overview of GO:0004818, covering its mechanism, key genes, disease associations, and research methods, with a focus on CRISPR-based models for functional studies.

Glutamate-tRNA ligase activity (GO:0004818) is the catalysis of the reaction: ATP + L-glutamate + tRNA(Glu) = AMP + diphosphate + L-glutamyl-tRNA(Glu). In other words, it is the enzymatic activity that joins the amino acid glutamate to its specific tRNA molecule, using ATP as an energy source and releasing AMP and diphosphate. This activity is essential for incorporating glutamate into proteins during translation.

Glutamate-tRNA ligase activity is fundamental to protein synthesis because it ensures that glutamate is correctly incorporated into nascent polypeptides, thereby maintaining proteome fidelity. Beyond translation, GluRS participates in indirect tRNA aminoacylation pathways that are essential for organellar and bacterial protein synthesis. The enzyme is also a target for drug development against pathogens such as Plasmodium falciparum, where structural differences in GluRS can be exploited for selective inhibition. In human cells, redox-dependent regulation of GluRS activity links translation to cellular redox status, with implications for oxidative stress-related diseases. Understanding this activity is therefore critical for basic biology, disease research, and therapeutic development.

The following genes and proteins are directly or functionally associated with glutamate-tRNA ligase activity (GO:0004818) and its related pathways.

Glutamate-tRNA ligase activity is regulated at multiple levels. The catalytic activity of GluRS is sensitive to redox conditions, with oxidative stress leading to reversible modification of cysteine residues and altered enzyme activity. In addition, the expression of aminoacyl-tRNA synthetases, including GluRS, can be regulated by the mTOR signaling pathway, which controls protein synthesis in response to nutrient availability. Furthermore, the indirect tRNA aminoacylation pathway involving GluRS is regulated by the availability of glutamyl-tRNA amidotransferase and the metabolic state of the cell. These regulatory mechanisms ensure that tRNA charging is coordinated with cellular growth and stress responses.

Mutations in aminoacyl-tRNA synthetases, including those related to glutamyl-tRNA synthetase, have been linked to neurological disorders such as Charcot-Marie-Tooth disease and encephalopathies. These mutations often impair tRNA charging and lead to protein synthesis defects in neurons, which are particularly sensitive to translational stress.

Dysregulation of aminoacyl-tRNA synthetases, including GluRS, is observed in various cancers. Elevated expression of these enzymes supports the high translational demand of cancer cells. Targeting GluRS activity with small-molecule inhibitors is being explored as a potential anticancer strategy.

Glutamyl-tRNA synthetase from Plasmodium falciparum, the malaria parasite, has unique structural features that distinguish it from the human enzyme. These differences make it an attractive target for antiparasitic drug development, and structural studies have provided a basis for designing selective inhibitors.

Mitochondrial glutamyl-tRNA synthetase (EARS2) is essential for mitochondrial translation. Mutations in EARS2 cause severe mitochondrial encephalopathy, highlighting the importance of GluRS activity in organellar protein synthesis.

Ribosome profiling (Ribo-seq) measures translation efficiency and can reveal changes in global protein synthesis upon GluRS perturbation. RNA-seq complements this by quantifying transcript levels of aminoacyl-tRNA synthetases and related genes. These methods are used to study how GluRS activity affects the translatome.

Mass spectrometry-based proteomics can detect changes in protein abundance and post-translational modifications. Aminoacylation assays using radiolabeled glutamate directly measure GluRS catalytic activity in vitro and in cell lysates.

X-ray crystallography and cryo-EM provide atomic-level insights into GluRS structure and substrate binding. Fluorescence microscopy of tagged GluRS allows visualization of its subcellular localization and dynamics.

Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to GluRS inhibitors or that interact with GluRS. Bioinformatics analysis of genomic and transcriptomic data reveals evolutionary conservation and disease associations.

Researchers studying glutamate-tRNA ligase activity-related genes often need to determine whether a candidate gene is causally involved in translation, disease, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of GO:0004818 and its associated pathways.

Glutamate-tRNA ligase activity (GO:0004818) is a fundamental molecular function that ensures the accurate incorporation of glutamate into proteins. Its catalytic mechanism, regulation by redox status, and involvement in indirect tRNA aminoacylation pathways highlight its importance in translation and cellular homeostasis. The enzyme is also a promising drug target in parasites and is linked to neurological and mitochondrial diseases. Advances in CRISPR-based models and high-throughput methods are enabling deeper functional studies of GluRS and its associated genes. EDITGENE provides comprehensive services to support these research efforts, from knockout and knock-in cell lines to CRISPR library screening and bioinformatics.